Prokarium Appoints Kristen Albright as Chief Executive Officer
Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, announced the appointment of Kristen Albright, PharmD, as Chief Executive Officer. Kristen is an accomplished industry leader with broad experience in finance, business development, and operations.
Prokarium is a biopharmaceutical company pioneering the field of microbial immunotherapy. Their pipeline is designed to unlock the next level of immuno-oncology by building on the most recent advances in cancer immunology.